Literature DB >> 11752702

Sequence analysis of the GP, NP, VP40 and VP24 genes of Ebola virus isolated from deceased, surviving and asymptomatically infected individuals during the 1996 outbreak in Gabon: comparative studies and phylogenetic characterization.

Eric M Leroy1, Sylvain Baize1, Elie Mavoungou2, Cristian Apetrei1.   

Abstract

The aims of this study were to determine if the clinical outcome of Ebola virus (EBOV) infection is associated with virus genetic structure and to document the genetic changes in the Gabon strains of EBOV by sequencing the GP, NP, VP40 and VP24 genes from deceased and surviving symptomatic and asymptomatic individuals. GP and NP sequences were identical in the three groups of patients and only one silent substitution occurred in the VP40 and VP24 genes in asymptomatic individuals. A strain from an asymptomatic individual had a reverse substitution to the Gabon-94 sequence, indicating that minor virus variants may cocirculate during an outbreak. These results suggest that the different clinical outcomes of EBOV infection do not result from virus mutations. Phylogenetic analysis confirmed that Gabon-96 belonged to the Zaire subtype of EBOV and revealed that synonymous substitution rates were higher than nonsynonymous substitution rates in the GP, VP40 and VP24 genes. In contrast, nonsynonymous substitutions predominated over synonymous substitutions in the NP gene of the two Gabon strains, pointing to divergent evolution of these strains and to selective pressures on this gene.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11752702     DOI: 10.1099/0022-1317-83-1-67

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  15 in total

1.  How Ebola impacts genetics of Western lowland gorilla populations.

Authors:  Pascaline J Le Gouar; Dominique Vallet; Laetitia David; Magdalena Bermejo; Sylvain Gatti; Florence Levréro; Eric J Petit; Nelly Ménard
Journal:  PLoS One       Date:  2009-12-18       Impact factor: 3.240

Review 2.  Ebola virus: a clear and present danger.

Authors:  Eileen M Burd
Journal:  J Clin Microbiol       Date:  2014-11-12       Impact factor: 5.948

3.  Marburgvirus genomics and association with a large hemorrhagic fever outbreak in Angola.

Authors:  Jonathan S Towner; Marina L Khristova; Tara K Sealy; Martin J Vincent; Bobbie R Erickson; Darcy A Bawiec; Amy L Hartman; James A Comer; Sherif R Zaki; Ute Ströher; Filomena Gomes da Silva; Fernando del Castillo; Pierre E Rollin; Thomas G Ksiazek; Stuart T Nichol
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

4.  Inflammatory responses in Ebola virus-infected patients.

Authors:  S Baize; E M Leroy; A J Georges; M-C Georges-Courbot; M Capron; I Bedjabaga; J Lansoud-Soukate; E Mavoungou
Journal:  Clin Exp Immunol       Date:  2002-04       Impact factor: 4.330

5.  Host genetic diversity enables Ebola hemorrhagic fever pathogenesis and resistance.

Authors:  Angela L Rasmussen; Atsushi Okumura; Martin T Ferris; Richard Green; Friederike Feldmann; Sara M Kelly; Dana P Scott; David Safronetz; Elaine Haddock; Rachel LaCasse; Matthew J Thomas; Pavel Sova; Victoria S Carter; Jeffrey M Weiss; Darla R Miller; Ginger D Shaw; Marcus J Korth; Mark T Heise; Ralph S Baric; Fernando Pardo-Manuel de Villena; Heinz Feldmann; Michael G Katze
Journal:  Science       Date:  2014-10-30       Impact factor: 47.728

6.  Isolates of Zaire ebolavirus from wild apes reveal genetic lineage and recombinants.

Authors:  Tatiana J Wittmann; Roman Biek; Alexandre Hassanin; Pierre Rouquet; Patricia Reed; Philippe Yaba; Xavier Pourrut; Leslie A Real; Jean-Paul Gonzalez; Eric M Leroy
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-17       Impact factor: 11.205

7.  Persistent infection with ebola virus under conditions of partial immunity.

Authors:  Manisha Gupta; Siddhartha Mahanty; Patricia Greer; Jonathan S Towner; Wun-Ju Shieh; Sherif R Zaki; Rafi Ahmed; Pierre E Rollin
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

8.  Ad35 and ad26 vaccine vectors induce potent and cross-reactive antibody and T-cell responses to multiple filovirus species.

Authors:  Roland Zahn; Gert Gillisen; Anna Roos; Marina Koning; Esmeralda van der Helm; Dirk Spek; Mo Weijtens; Maria Grazia Pau; Katarina Radošević; Gerrit Jan Weverling; Jerome Custers; Jort Vellinga; Hanneke Schuitemaker; Jaap Goudsmit; Ariane Rodríguez
Journal:  PLoS One       Date:  2012-12-06       Impact factor: 3.240

9.  "Filoviruses": a real pandemic threat?

Authors:  Byron E E Martina; Albert D M E Osterhaus
Journal:  EMBO Mol Med       Date:  2009-04       Impact factor: 12.137

10.  Ebolavirus nucleoprotein C-termini potently attract single domain antibodies enabling monoclonal affinity reagent sandwich assay (MARSA) formulation.

Authors:  Laura J Sherwood; Andrew Hayhurst
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.